v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NON-CONTROLLING INTERESTS AND EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Redeemable Non-Controlling Interests
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Redeemable Non-Controlling Interests
Beginning balance at Dec. 31, 2023   $ 654          
Redeemable Non-Controlling Interests              
Foreign currency translation adjustment $ (8) (2)     $ (8)    
Recognition of non-controlling interest upon capital investment   19          
Re-measurement of non-controlling interest   18          
Net income (loss)   (20)          
Ending balance at Mar. 31, 2024   651          
Beginning balance (in shares) at Dec. 31, 2023     2,071,144        
Beginning balance at Dec. 31, 2023 12,028   $ 0 $ 42,264 (421) $ (30,594) $ 779
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     2,421        
Exercise of stock options 18     18      
Stock-based compensation 493     493      
Issuance of common stock for settlement of RSUs (in shares)     13,160        
Shares withheld related to net share settlement (in shares)     (478)        
Shares withheld related to net share settlement (36)     (36)      
Re-measurement of non-controlling interest       (18)      
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax (8)       (8)    
Foreign currency translation adjustment (8) (2)     (8)    
Net income (loss) (643)         (654) 11
Other 4     4      
Ending balance (in shares) at Mar. 31, 2024     2,086,247        
Ending balance at Mar. 31, 2024 11,848   $ 0 42,743 (437) (31,248) 790
Beginning balance at Dec. 31, 2024   93          
Redeemable Non-Controlling Interests              
Foreign currency translation adjustment $ 31       31    
Net income (loss)   (18)          
Ending balance at Mar. 31, 2025   $ 93          
Beginning balance (in shares) at Dec. 31, 2024 2,107,953   2,107,953        
Beginning balance at Dec. 31, 2024 $ 22,383   $ 0 42,801 (517) (20,726) 825
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares) 655   657        
Exercise of stock options $ 8     8      
Stock-based compensation 448     448      
Issuance of common stock for settlement of RSUs (in shares)     10,293        
Shares withheld related to net share settlement (in shares)     (460)        
Shares withheld related to net share settlement (33)     (33)      
Repurchase of common stock (in shares)     (26,587)        
Repurchase of common stock (1,800)     (1,800)      
Re-measurement of non-controlling interest (18)            
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax 1       1    
Foreign currency translation adjustment 31       31    
Net income (loss) $ 1,792         1,780 12
Ending balance (in shares) at Mar. 31, 2025 2,091,856   2,091,856        
Ending balance at Mar. 31, 2025 $ 22,812   $ 0 $ 41,406 $ (485) $ (18,946) $ 837